News Nexien BioPharma, Inc.

Equities

NXEN

US65343D1000

Market Closed - OTC Markets Other stock markets 10:25:07 2024-05-13 EDT			5-day change	1st Jan Change
0.0163 ^USD	-28.04%		0.00%	-37.07%

02-20	Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-20	CI
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-28	CI
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-17	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	23-02-08	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-02-08	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	22-11-09	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	22-11-09	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-09-28	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	22-09-28	CI
Nexien BioPharma, Inc. Auditor Raises 'Going Concern' Doubt	22-09-27	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	22-05-12	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	22-05-12	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	22-02-08	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	22-02-08	CI
NEXIEN BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-01-21	AQ
Nexien BioPharma, Inc. announced that it has received $0.15 million in funding from Quick Capital, LLC	22-01-17	CI
NEXIEN BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION (form 10-Q)	21-11-22	AQ
Nexien BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	21-11-22	CI
NEXIEN BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	21-10-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Nexien BioPharma, Inc.

Equities

NXEN

US65343D1000

Summary

Filters